Reach Surgical, the surgical solutions division of Singapore-based medical device company Genesis MedTech, has received CE Mark approval for SOUND REACH Swift, an ultrasonic shears device designed for open surgical procedures such as breast and thyroid surgeries.
CE Mark approval means the product meets the European Union’s safety, performance and labelling requirements and can be legally marketed in the European Economic Area (EEA).
As the number of thyroid and breast cancer cases continues to rise worldwide, there is increasing demand for surgical tools that can help protect surrounding tissue, improve precision, and simplify procedures in the operating room.
SOUND REACH Swift features a plug-and-play single-unit design that combines a lightweight power transducer with a fine curved-tip blade, enabling efficient and consistent ultrasonic energy delivery. This allows surgeons to perform precise dissection in confined anatomy and effectively seal blood vessels up to 5 mm in size. By eliminating the need for conventional handpiece assembly and separate handpiece management and sterilisation, the device also helps simplify preoperative preparation.
The forceps-style design, commonly used in open surgery, allows tissue grasping, dissection, and coagulation using a single instrument, reducing the need for instrument exchanges during surgery. Its compact, lightweight design improves hand manoeuvrability and helps reduce surgeon fatigue during prolonged procedures.
According to the company, these features improve ease of use and workflow efficiency during open surgery, particularly in thyroid and breast surgeries performed within confined anatomical spaces and near critical structures. In such settings, controlled energy delivery and effective thermal management are essential to support safe and efficient surgical outcomes.
Reach Surgical said SOUND REACH Swift has been designed to meet these procedural requirements and challenges.
The launch of SOUND REACH Swift further expands the company’s energy portfolio into open surgery and complements its ultrasonic and advanced bipolar technologies available on the ENER REACH OP9 platform, which supports both energy modalities within a single system.
